Valneva SE (VALN) Operating Leases (2020 - 2026)

Valneva SE (VALN) posted quarterly Operating Leases of $27.8 million for Q1 2026, down 10.39% year-on-year from $31.0 million in Q1 2025, and down 3.59% on a QoQ basis from $28.8 million in Q4 2025.

Valneva SE (VALN) Operating Leases (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Operating Leases for 7 consecutive years, with $27.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Operating Leases fell 10.39% year-over-year to $27.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.8 million (down 10.39% YoY) and the FY2025 annual result came in at $28.8 million, down 12.43% from the prior year.
  • Operating Leases fell to $27.8 million in Q1 2026 per VALN's latest filing, from $28.8 million in the prior quarter.
  • Over the last five years, Operating Leases for VALN reached as high as $61.0 million in Q4 2022 and fell as low as $27.8 million in Q1 2026.
  • A 5-year average of $37.9 million and a median of $31.7 million in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2023 — Operating Leases plunged 47.09% — and 2025, when it retreated 1.02%.
  • Year by year, Operating Leases stood at $61.0 million in 2022, then slumped by 40.33% to $36.4 million in 2023, then fell by 9.47% to $32.9 million in 2024, then retreated by 12.43% to $28.8 million in 2025, then decreased by 3.59% to $27.8 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $27.8 million, $28.8 million, and $29.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.80 Mn
Dec 31, 2025 28.84 Mn
Sep 30, 2025 28.96 Mn
Jun 30, 2025 29.47 Mn
Mar 31, 2025 31.03 Mn
Dec 31, 2024 32.93 Mn
Sep 30, 2024 29.60 Mn
Jun 30, 2024 30.19 Mn
Mar 31, 2024 31.35 Mn
Dec 31, 2023 36.38 Mn
Sep 30, 2023 31.69 Mn
Jun 30, 2023 31.73 Mn
Mar 31, 2023 33.63 Mn
Dec 31, 2022 60.96 Mn
Sep 30, 2022 59.91 Mn
Jun 30, 2022 59.10 Mn
Mar 31, 2022 59.93 Mn
Dec 31, 2021 64.66 Mn
Dec 31, 2020 59.27 Mn